D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round.

The National Defense Authorization Act is traditionally a strong bipartisan bill that lays out the nation’s defense policies.

Ukraine, the Supreme Court hears a campaign finance case involving JD Vance and Miami holds its mayor's election.

Manchester City are aiming to take advantage of uncertainty at the Santiago Bernabéu when they face Real Madrid in the ...

"The EU Commission should be disbanded in favor of an elected body and the EU President should be directly elected. The current system is rule by bureaucracy, not democracy," he wrote on his social ...

Ukrainian President Volodymyr Zelenskyy is continuing his diplomacy tour across Europe amid Trump’s claims that Europe is ...

Pope Leo XIV insisted Tuesday that Europe must have a role in any Ukraine peace deal and criticized what he said was the ...

Major stock indexes closed mixed Tuesday, a day before the Federal Reserve decision on whether to cut interest rates.

President Donald Trump's top national security advisers briefed members of Congress about the administration's campaign ...

Zelensky says he could hold wartime election after Trump criticism - Zelensky says he is willing to hold a wartime election, ...

Carmaker Stellantis is teaming up with Estonia-based ride-hailing platform Bolt to deploy driverless vehicles across Europe, ...

Trump isn’t the first to overstate new investments. President Joe Biden said in 2024 that his bipartisan CHIPS and Science Act had attracted $640 billion in private investments; economists told ...